Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,088
Closed -$339K 238
2025
Q1
$339K Sell
1,088
-180
-14% -$53.2K 0.02% 132
2024
Q4
$330K Buy
1,268
+1
+0.1% +$297 0.02% 129
2024
Q3
$408K Buy
1,267
+20
+2% +$6.54K 0.03% 128
2024
Q2
$390K Buy
1,247
+6
+0.5% +$1.76K 0.03% 133
2024
Q1
$353K Hold
1,241
0.02% 136
2023
Q4
$357K Buy
+1,241
New +$338K 0.03% 127

Other funds holding AMGN

Full Sail Capital's AMGN Position: Q2 2025 in Review

Full Sail Capital sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,088 shares — an estimated $339K sold.

Full Sail Capital first reported a position in AMGN in Q4 2023 and held it in 6 quarters. The position peaked at $408K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Full Sail Capital reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Full Sail Capital sold 1,088 Amgen shares in Q2 2025, an estimated $339K.
  • Full Sail Capital first reported a position in Amgen in Q4 2023 and held it in 6 quarters.
  • Full Sail Capital's Amgen position peaked at $408K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Full Sail Capital's 13F filing for Q2 2025, filed 14 Aug 2025.